85 related articles for article (PubMed ID: 8399310)
21. Structural requirements for anion substrates of the methotrexate transport system in L1210 cells.
Henderson GB; Zevely EM
Arch Biochem Biophys; 1983 Mar; 221(2):438-46. PubMed ID: 6838199
[TBL] [Abstract][Full Text] [Related]
22. Properties of an anion/H+ cotransport system in L1210 cells that utilizes phthalate as a nonphysiological substrate.
Henderson GB; Zevely EM
J Membr Biol; 1986; 89(1):99-106. PubMed ID: 3959065
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the transport mechanism for methotrexate in L1210 mouse leukemia cells.
Henderson GB
Prog Clin Biol Res; 1983; 132B():415-23. PubMed ID: 6634763
[TBL] [Abstract][Full Text] [Related]
24. Common properties of hepatocellular uptake of cholate, iodipamide and antamanide, as distinct from the uptake of bromosulfophthalein.
Petzinger E; Joppen C; Frimmer M
Naunyn Schmiedebergs Arch Pharmacol; 1983 Mar; 322(2):174-9. PubMed ID: 6688124
[TBL] [Abstract][Full Text] [Related]
25. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
[TBL] [Abstract][Full Text] [Related]
26. Antifolate transport in L1210 leukemia cells. Kinetic evidence for the non-identity of carriers for influx and efflux.
Dembo M; Sirotnak FM
Biochim Biophys Acta; 1976 Oct; 448(3):505-16. PubMed ID: 974145
[TBL] [Abstract][Full Text] [Related]
27. A novel class of genetic variants of the L1210 cell up-regulated for folate analogue transport inward. Isolation, characterization, and degree of metabolic instability of the system.
Sirotnak FM; Moccio DM; Yang CH
J Biol Chem; 1984 Nov; 259(21):13139-44. PubMed ID: 6490649
[TBL] [Abstract][Full Text] [Related]
28. Transport of methotrexate in L1210 cells. Mechanism for inhibition by p-chloromercuriphenylsulfonate and N-ethylmaleimide.
Henderson GB; Zevely EM
Biochim Biophys Acta; 1981 Jan; 640(2):549-56. PubMed ID: 6260257
[TBL] [Abstract][Full Text] [Related]
29. Modulation of methotrexate resistance by genistein in murine leukemia L1210 cells.
Xuan Y; Hacker MP; Tritton TR; Bhushan A
Oncol Rep; 1998; 5(2):419-21. PubMed ID: 9468571
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of methotrexate polyglutamates in L1210 murine leukemia cells.
Whitehead VM
Cancer Res; 1977 Feb; 37(2):408-12. PubMed ID: 832265
[TBL] [Abstract][Full Text] [Related]
31. Protein binding as a component of drug interaction in cellular pharmacokinetic studies. Effects of probenecid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro.
Gewirtz DA; Holt SA
Biochem Pharmacol; 1985 Mar; 34(6):747-54. PubMed ID: 3977951
[TBL] [Abstract][Full Text] [Related]
32. The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.
McGown AT; Poppitt DG; Swindell R; Fox BW
Cancer Chemother Pharmacol; 1984; 13(1):47-53. PubMed ID: 6733842
[TBL] [Abstract][Full Text] [Related]
33. Effects of metabolic deprivation on methotrexate transport in L1210 leukemia cells: further evidence for separate influx and efflux systems with different energetic requirements.
Dembo M; Sirotnak FM; Moccio DM
J Membr Biol; 1984; 78(1):9-17. PubMed ID: 6708095
[TBL] [Abstract][Full Text] [Related]
34. Irreversible inactivation of the methotrexate transport system of L1210 cells by carbodiimide-activated substrates.
Henderson GB; Zevely EM; Huennekens FM
J Biol Chem; 1980 May; 255(10):4829-33. PubMed ID: 7372613
[TBL] [Abstract][Full Text] [Related]
35. Effect of [3H]methotrexate impurities on apparent transport of methotrexate by a sensitive and resistant L1210 cell line.
Kamen BA; Cashmore AR; Dreyer RN; Moroson BA; Hsieh P; Bertino JR
J Biol Chem; 1980 Apr; 255(8):3254-7. PubMed ID: 6965938
[TBL] [Abstract][Full Text] [Related]
36. Enhancement of folate analogue transport inward in L1210 cells during methotrexate therapy of leukemic mice: evidence of the nature of the effect, possible host mediation, and pharmacokinetic significance.
Sirotnak FM; Poser RE; Barrueco JR
Cancer Res; 1987 Oct; 47(20):5334-9. PubMed ID: 3498533
[TBL] [Abstract][Full Text] [Related]
37. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
[TBL] [Abstract][Full Text] [Related]
38. Use of non-physiological buffer systems in the analysis of methotrexate transport in L1210 cells.
Henderson GB; Zevely EM
Biochem Int; 1983 Apr; 6(4):507-15. PubMed ID: 6679721
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of methionine uptake by methotrexate in mouse leukemia L1210 cells.
Scanlon KJ; Cashmore AR; Kashani-Sabet M; Pallai M; Dreyer RN; Moroson BA; Saketos M
Cancer Chemother Pharmacol; 1987; 19(1):21-4. PubMed ID: 3102093
[TBL] [Abstract][Full Text] [Related]
40. Improved methotrexate therapy of murine tumors obtained by probenecid-mediated pharmacological modulation at the level of membrane transport.
Sirotnak FM; Moccio DM; Hancock CH; Young CW
Cancer Res; 1981 Oct; 41(10):3944-9. PubMed ID: 7285003
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
